Skip to Content

Personalised Dosing – Patient-centered Dupilumab Dosing Regimen in AD

Hear Lotte S. Spekhorst presents her study presented at this year’s EADV, investigating different dupilumab dosing regimens in patients with controlled atopic dermatitis (AD)

Get access to the article

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top